滚动资讯
CellB cell deficiency limits exercise capacity by remodeling liver glutamate metabolismCellA phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoesCellp53 safeguards chemical reprogramming of human somatic cells toward pluripotencyCell2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunityCellGut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockadeFierceBiotechAACR: Endeavoring to go global, Zai Lab offers reality check on China’s biotech ascentNVIDIAGoogle developing inference AI chips to rival Nvidia - qz.comCorningSpring book sale returns to benefit Southeast Steuben County Library - WETMBioPharma DiveRFK Jr. defends HHS tenure, 12% proposed budget cutInsilico MedicineInsilico Medicine Highlights AI Benchmarking Platform for Drug Discovery - TipRanksBDBD Wong to Star in Solo Performance of The Glass Menagerie for Philadelphia Theatre Company - TheaterManiaIlluminaTsinghua University brings hands-on multiomics training to young scientists - Illumina
FierceBiotech 2025年12月9日

辉瑞再度押注肥胖症治疗，斥资1.5亿美元预付款引进复星医药GLP-1药物。

辉瑞再度押注肥胖症治疗，斥资1.5亿美元预付款引进复星医药GLP-1药物。

原文
暂时没有全文，请查看原始来源。